The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Financial toxicity among patients with lung cancer in a publicly funded health care system.
 
Doreen Anuli Ezeife
No Relationships to Disclose
 
Joshua Morganstein
No Relationships to Disclose
 
Sally C Lau
No Relationships to Disclose
 
Lisa Le
No Relationships to Disclose
 
David Cella
Stock and Other Ownership Interests - FACIT.org
Consulting or Advisory Role - Abbvie; Astellas Pharma; Bayer; GlaxoSmithKline; Novartis; Pfizer; PledPharma; Puma Biotechnology
Research Funding - Bayer (Inst); Genentech (Inst); Ipsen (Inst); Novartis (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Astellas Pharma; Ipsen
 
Penelope Ann Bradbury
Honoraria - Abbvie; Merck; Pfizer
 
Geoffrey Liu
Honoraria - AstraZeneca; AstraZeneca/MedImmune; Merck Serono; Novartis Canada Pharmaceuticals Inc; Pfizer; Roche Canada; Takeda
Consulting or Advisory Role - Abbvie; AstraZeneca/MedImmune; Novartis; Takeda
Speakers' Bureau - AstraZeneca
 
Adrian G. Sacher
Honoraria - AstraZeneca
Travel, Accommodations, Expenses - AstraZeneca; Genentech/Roche; Gritstone Bio; Pfizer
 
Frances A. Shepherd
Stock and Other Ownership Interests - AstraZeneca; Lilly
Honoraria - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Lilly; Merck Serono; Merck Sharp & Dohme; Roche/Genentech
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Lilly; Merck Serono
Research Funding - AstraZeneca/MedImmune (Inst); Bristol-Myers Squibb (Inst); Lilly (Inst); Merrimack (Inst); Pfizer (Inst); Roche Canada (Inst)
 
Natasha B. Leighl
Research Funding - Novartis (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Bristol-Myers Squibb; Merck Sharp & Dohme; Pfizer